Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |